India’s institutions now need to upgrade TTOs as strategic innovation units rather than administrative support cells
The once-daily oral therapy is the first and only tyrosine kinase 2 (TYK2) inhibitor approved in the European Union for this indication, marking a significant expansion of its immunology portfolio
The move targets long-standing bottlenecks in MSC science, including cell-to-cell variability, immunocompatibility concerns, and inefficient manufacturing workflows
In collaboration with the Soham Foundation, the initiative focused on perimenopause, menopause, and hormone replacement therapy awareness at BESCOM’s Bengaluru headquarters.
The public health summit in Addis Ababa will bring together policymakers, scientists, healthcare leaders, and global partners
Initiative launched with Tata 1mg to benefit 70,000 people across 70 remote villages in Kalahandi region
Former DCGI and now advisor to UP CM highlights medical device growth, healthcare expansion, and investment opportunities in the state
The leading cancer hospital urges carrier screening to prevent thalassemia burden
The deal positions MilliporeSigma at the center of commercial manufacturing for three breakthrough gene therapies targeting sickle cell disease, ?-thalassemia, and cerebral adrenoleukodystrophy
The partnership will focus on diabetes and NCD awareness, rare disease screening, and deployment of mobile medical units
Subscribe To Our Newsletter & Stay Updated
